Fastest delivery:
Order by 02:00pm
Swift, discreet, and cost-free delivery! Arrives as quickly as the next working day.
Our team of doctors and prescribers, and our support staff, are all UK-based.
We're on hand to offer free support and advice by email and telephone (Mon - Fri 09:00 - 18:00).
based on over 170 reviews collected on Google.
BETNOVATE Lotion is a potent topical corticosteroid indicated for adults, elderly and
children over 1 year for the relief of the inflammatory and pruritic manifestations of
steroid responsive dermatoses. These include the following:
• Atopic dermatitis (including infantile atopic dermatitis)
• Nummular dermatitis (discoid eczema)
• Prurigo nodularis
• Psoriasis (excluding widespread plaque psoriasis)
• Lichen simplex chronicus (neurodermatitis) and lichen planus
• Seborrhoeic dermatitis
• Irritant or allergic contact dermatitis
• Discoid lupus erythematosus
• Insect bite reactions
• Miliaria (prickly heat); and
• Adjunct to systemic steroid therapy in generalised erythroderma.
The following conditions should not be treated with BETNOVATE Lotion:
• Untreated cutaneous infections
• Rosacea
• Acne vulgaris
• Pruritus without inflammation
• Perianal and genital pruritus
• Hypersensitivity to the preparations.
• Perioral dermatitis
BETNOVATE Lotion is contraindicated in dermatoses in infants under one year of
age, including dermatitis.
BETNOVATE should not be used in patients with a history of local hypersensitivity to
corticosteroids or to any of the excipients in the preparation. Local hypersensitivity
reactions may resemble symptoms of the condition under treatment.
BETNOVATE Lotion is especially appropriate for treatment of hairy areas or when a
minimal application to a large area is required.
Apply thinly and gently rub in using only enough to cover the entire affected area
once or twice daily for up to 4 weeks until improvement occurs, then reduce the
frequency of application or change the treatment to a less potent preparation. Allow
adequate time for absorption after each application before applying an emollient.
In the more resistant lesions, such as the thickened plaques of psoriasis on the elbows and knees, the effect of BETNOVATE Lotion can be enhanced, if necessary, by occluding the treatment area with polythene film. Overnight occlusion only is usually adequate to bring about a satisfactory response in such lesions; thereafter, improvement can usually be maintained by regular application without occlusion. If the condition worsens or does not improve within 2-4 weeks, treatment and diagnosis should be re-evaluated.
Due to the flammable nature of BETNOVATE Lotion, patients should avoid smoking
or being near an open flame during application and immediately after use.
BETNOVATE Lotion also contains:
• methyl hydroxybenzoate
• xanthan gum
• cetostearyl alcohol
• liquid paraffin (see Section 4.4 Special warnings and precautions for use)
• isopropyl alcohol
• glycerol
• cetomacrogol 1000
• sodium citrate
• citric acid monohydrate
• purified water
BETNOVATE Lotion does not contain lanolin.
BETNOVATE Lotion contains parabens.
Possible side effects include but are not limited to opportunistic infections, local hypersensitivity, Cushingoid features (very rare), delayed weight gain in children, osteoporosis, glaucoma, hyperglycaemia, cataracts, hypertension, obesity, increased weight, skin pain, allergic dermatitis.